The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us

 

CONTACT: LORELEI FLANIGAN
2130 Medical Laboratories
Iowa City IA 52242
(319) 335-9585; fax (319) 335-8034
e-mail: lorelei-flanigan@uiowa.edu

Release: April 23, 1999

Asthma study focuses on environmentally friendly delivery of investigational drug

IOWA CITY, Iowa -- A 14-week asthma study will begin soon at the University of Iowa to test the safety and effectiveness of how an investigational drug is delivered to a patient's lungs.

The combination drug of salmeterol/fluticasone propionate will be compared with the same drugs individually as well as with an inactive substance. All of the drugs will be given by metered dose inhalers (MDIs) with a propellant that does not contain chlorofluorocarbons (CFCs). Most asthma medications in MDIs use a propellant containing CFCs, which have been found to be harmful to the environment.

Study participants will make up to 10 visits to the UI Hospitals and Clinics for evaluation. Compensation is available.

For more information, contact Suzie Quinn at (319) 356-1659 or (800) 356-1659.